'use client';

import Navbar from '../../components/Navbar';
import Footer from '../../components/Footer';
import Link from 'next/link';

export default function NovelBiologicsPage() {
  return (
    <div className="min-h-screen bg-white">
      <Navbar />

      {/* Header Section */}
      <div className="bg-purple-600 text-white py-16">
        <div className="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8">
          <div className="flex items-center mb-4">
            <Link href="/products" className="text-white hover:text-purple-200 mr-4">
              ‚Üê Back to Products
            </Link>
            <span className="text-purple-200">|</span>
            <span className="ml-4 text-purple-200">Novel Biologics</span>
          </div>
          <h1 className="text-4xl md:text-5xl font-bold mb-4">NOVEL BIOLOGICS</h1>
          <p className="text-xl opacity-90 max-w-3xl">
            Cutting-edge biologic therapies developed through innovative research and advanced technology. 
            Our novel biologics represent the next generation of treatment options for complex and chronic diseases.
          </p>
        </div>
      </div>

      {/* Content Section */}
      <div className="py-16">
        <div className="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8">
          
          {/* Pipeline Products Table */}
          <div className="mb-16">
            <h2 className="text-3xl font-bold text-gray-900 mb-8">Pipeline Products</h2>
            
            <div className="bg-white border border-gray-200 rounded-lg overflow-hidden shadow-sm">
              <table className="min-w-full divide-y divide-gray-200">
                <thead className="bg-gray-50">
                  <tr>
                    <th className="px-6 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">
                      Sl. No
                    </th>
                    <th className="px-6 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">
                      Product Name
                    </th>
                    <th className="px-6 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">
                      Therapeutic Area
                    </th>
                    <th className="px-6 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">
                      Development Stage
                    </th>
                    <th className="px-6 py-3 text-left text-xs font-medium text-gray-500 uppercase tracking-wider">
                      Indication
                    </th>
                  </tr>
                </thead>
                <tbody className="bg-white divide-y divide-gray-200">
                  <tr className="hover:bg-gray-50">
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      1
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm font-medium text-gray-900">
                      BioMab-CD20
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Oncology
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Phase III
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Non-Hodgkin Lymphoma
                    </td>
                  </tr>
                  <tr className="hover:bg-gray-50">
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      2
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm font-medium text-gray-900">
                      BioMab-HER2
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Oncology
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Phase II
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Breast Cancer
                    </td>
                  </tr>
                  <tr className="hover:bg-gray-50">
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      3
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm font-medium text-gray-900">
                      BioMab-EGFR
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Oncology
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Phase II
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Lung Cancer
                    </td>
                  </tr>
                  <tr className="hover:bg-gray-50">
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      4
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm font-medium text-gray-900">
                      RheumaBiosim
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Immunology
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Phase III
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Rheumatoid Arthritis
                    </td>
                  </tr>
                  <tr className="hover:bg-gray-50">
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      5
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm font-medium text-gray-900">
                      PsoriaBiosim
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Dermatology
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Phase II
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Psoriasis
                    </td>
                  </tr>
                  <tr className="hover:bg-gray-50">
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      6
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm font-medium text-gray-900">
                      NeuroBiosim
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Neurology
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Phase I
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Multiple Sclerosis
                    </td>
                  </tr>
                  <tr className="hover:bg-gray-50">
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      7
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm font-medium text-gray-900">
                      GastroBiosim
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Gastroenterology
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Phase II
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Inflammatory Bowel Disease
                    </td>
                  </tr>
                  <tr className="hover:bg-gray-50">
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      8
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm font-medium text-gray-900">
                      CardioBiosim
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Cardiology
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Phase I
                    </td>
                    <td className="px-6 py-4 whitespace-nowrap text-sm text-gray-900">
                      Heart Failure
                    </td>
                  </tr>
                </tbody>
              </table>
            </div>
          </div>

          {/* Research & Development Section */}
          <div className="grid grid-cols-1 lg:grid-cols-2 gap-12 items-center mb-16">
            <div>
              <h2 className="text-3xl font-bold text-gray-900 mb-6">
                Pioneering Biologics Research
              </h2>
              <p className="text-lg text-gray-700 leading-relaxed mb-6">
                Our novel biologics program represents the forefront of biomedical innovation, focusing on developing 
                breakthrough therapies for diseases with significant unmet medical needs. We leverage cutting-edge 
                biotechnology platforms and advanced manufacturing processes to create complex biologic molecules.
              </p>
              <p className="text-lg text-gray-700 leading-relaxed mb-6">
                Through strategic partnerships with leading research institutions and continuous investment in 
                R&D infrastructure, we are building a robust pipeline of novel biologics that address critical health 
                challenges across multiple therapeutic areas.
              </p>
              <p className="text-lg text-gray-700 leading-relaxed mb-8">
                Our commitment to scientific excellence and patient-centric innovation drives us to push the boundaries 
                of what's possible in biologic drug development, bringing hope to patients worldwide.
              </p>
              <Link 
                href="/products/novel-biologics/research"
                className="inline-flex items-center text-purple-600 font-semibold text-lg hover:text-purple-700 transition-colors duration-300"
              >
                Learn More About Our Research
                <svg className="w-5 h-5 ml-2" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                  <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M17 8l4 4m0 0l-4 4m4-4H3" />
                </svg>
              </Link>
            </div>
            <div className="bg-purple-50 rounded-lg p-8">
              <div className="grid grid-cols-2 gap-6">
                <div className="text-center">
                  <div className="w-16 h-16 bg-purple-100 rounded-full flex items-center justify-center mx-auto mb-3">
                    <svg className="w-8 h-8 text-purple-600" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                      <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z" />
                    </svg>
                  </div>
                  <h3 className="font-semibold text-gray-800">Advanced R&D</h3>
                  <p className="text-gray-600 text-sm mt-1">State-of-the-art research facilities</p>
                </div>
                <div className="text-center">
                  <div className="w-16 h-16 bg-purple-100 rounded-full flex items-center justify-center mx-auto mb-3">
                    <svg className="w-8 h-8 text-purple-600" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                      <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M13 10V3L4 14h7v7l9-11h-7z" />
                    </svg>
                  </div>
                  <h3 className="font-semibold text-gray-800">Innovation</h3>
                  <p className="text-gray-600 text-sm mt-1">Breakthrough biologic platforms</p>
                </div>
                <div className="text-center">
                  <div className="w-16 h-16 bg-purple-100 rounded-full flex items-center justify-center mx-auto mb-3">
                    <svg className="w-8 h-8 text-purple-600" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                      <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z" />
                    </svg>
                  </div>
                  <h3 className="font-semibold text-gray-800">Quality</h3>
                  <p className="text-gray-600 text-sm mt-1">Rigorous testing standards</p>
                </div>
                <div className="text-center">
                  <div className="w-16 h-16 bg-purple-100 rounded-full flex items-center justify-center mx-auto mb-3">
                    <svg className="w-8 h-8 text-purple-600" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                      <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M3.055 11H5a2 2 0 012 2v1a2 2 0 002 2 2 2 0 104 0 2 2 0 012-2h1.064M15 20.488V18a2 2 0 012-2h3.064M21 12a9 9 0 11-18 0 9 9 0 0118 0z" />
                    </svg>
                  </div>
                  <h3 className="font-semibold text-gray-800">Global Impact</h3>
                  <p className="text-gray-600 text-sm mt-1">Worldwide patient reach</p>
                </div>
              </div>
            </div>
          </div>

          {/* Technology Platforms Section */}
          <div className="mb-16">
            <h2 className="text-3xl font-bold text-gray-900 mb-8">Technology Platforms</h2>
            <div className="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6">
              <div className="bg-white border border-gray-200 rounded-lg p-6 hover:shadow-lg transition-shadow duration-300">
                <div className="w-12 h-12 bg-purple-100 rounded-full flex items-center justify-center mb-4">
                  <svg className="w-6 h-6 text-purple-600" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M9 3v2m6-2v2M9 19v2m6-2v2M5 9H3m2 6H3m18-6h-2m2 6h-2M7 19h10a2 2 0 002-2V7a2 2 0 00-2-2H7a2 2 0 00-2 2v10a2 2 0 002 2zM9 9h6v6H9V9z" />
                  </svg>
                </div>
                <h3 className="font-semibold text-gray-800 mb-2">Monoclonal Antibodies</h3>
                <p className="text-gray-600 text-sm">Advanced mAb platforms for targeted cancer and autoimmune therapies</p>
              </div>
              
              <div className="bg-white border border-gray-200 rounded-lg p-6 hover:shadow-lg transition-shadow duration-300">
                <div className="w-12 h-12 bg-purple-100 rounded-full flex items-center justify-center mb-4">
                  <svg className="w-6 h-6 text-purple-600" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M20 7l-8-4-8 4m16 0l-8 4m8-4v10l-8 4m0-10L4 7m8 4v10M4 7v10l8 4" />
                  </svg>
                </div>
                <h3 className="font-semibold text-gray-800 mb-2">Recombinant Proteins</h3>
                <p className="text-gray-600 text-sm">Cutting-edge protein expression and purification technologies</p>
              </div>
              
              <div className="bg-white border border-gray-200 rounded-lg p-6 hover:shadow-lg transition-shadow duration-300">
                <div className="w-12 h-12 bg-purple-100 rounded-full flex items-center justify-center mb-4">
                  <svg className="w-6 h-6 text-purple-600" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M12 8v4l3 3m6-3a9 9 0 11-18 0 9 9 0 0118 0z" />
                  </svg>
                </div>
                <h3 className="font-semibold text-gray-800 mb-2">Cell Therapy</h3>
                <p className="text-gray-600 text-sm">Innovative cellular therapies for regenerative medicine</p>
              </div>
              
              <div className="bg-white border border-gray-200 rounded-lg p-6 hover:shadow-lg transition-shadow duration-300">
                <div className="w-12 h-12 bg-purple-100 rounded-full flex items-center justify-center mb-4">
                  <svg className="w-6 h-6 text-purple-600" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M13 10V3L4 14h7v7l9-11h-7z" />
                  </svg>
                </div>
                <h3 className="font-semibold text-gray-800 mb-2">Gene Therapy</h3>
                <p className="text-gray-600 text-sm">Next-generation gene editing and delivery systems</p>
              </div>
              
              <div className="bg-white border border-gray-200 rounded-lg p-6 hover:shadow-lg transition-shadow duration-300">
                <div className="w-12 h-12 bg-purple-100 rounded-full flex items-center justify-center mb-4">
                  <svg className="w-6 h-6 text-purple-600" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M4.318 6.318a4.5 4.5 0 000 6.364L12 20.364l7.682-7.682a4.5 4.5 0 00-6.364-6.364L12 7.636l-1.318-1.318a4.5 4.5 0 00-6.364 0z" />
                  </svg>
                </div>
                <h3 className="font-semibold text-gray-800 mb-2">Vaccines</h3>
                <p className="text-gray-600 text-sm">Novel vaccine platforms for infectious diseases</p>
              </div>
              
              <div className="bg-white border border-gray-200 rounded-lg p-6 hover:shadow-lg transition-shadow duration-300">
                <div className="w-12 h-12 bg-purple-100 rounded-full flex items-center justify-center mb-4">
                  <svg className="w-6 h-6 text-purple-600" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path strokeLinecap="round" strokeLinejoin="round" strokeWidth={2} d="M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2m-3 7h3m-3 4h3m-6-4h.01M9 16h.01" />
                  </svg>
                </div>
                <h3 className="font-semibold text-gray-800 mb-2">Diagnostic Tools</h3>
                <p className="text-gray-600 text-sm">Companion diagnostics for personalized medicine</p>
              </div>
            </div>
          </div>

          {/* Clinical Development Section */}
          <div className="bg-purple-50 rounded-lg p-8">
            <h3 className="text-2xl font-bold text-gray-900 mb-6">Clinical Development Excellence</h3>
            <div className="grid grid-cols-1 md:grid-cols-3 gap-8">
              <div>
                <h4 className="font-semibold text-gray-800 mb-3">Global Clinical Trials</h4>
                <p className="text-gray-600 text-sm">
                  Our clinical development program spans multiple countries, ensuring diverse patient populations 
                  and robust data collection for regulatory submissions worldwide.
                </p>
              </div>
              <div>
                <h4 className="font-semibold text-gray-800 mb-3">Regulatory Strategy</h4>
                <p className="text-gray-600 text-sm">
                  Comprehensive regulatory planning and engagement with global health authorities to ensure 
                  efficient approval pathways for our novel biologics.
                </p>
              </div>
              <div>
                <h4 className="font-semibold text-gray-800 mb-3">Patient Access</h4>
                <p className="text-gray-600 text-sm">
                  Developing innovative access programs to ensure patients can benefit from our breakthrough 
                  therapies as soon as they become available.
                </p>
              </div>
            </div>
          </div>
        </div>
      </div>

      <Footer />
    </div>
  );
}
